Theophylline Explained

Watchedfields:changed
Verifiedrevid:470606142
Iupac Name:1,3-dimethyl-7H-purine-2,6-dione
Width:150
Width2:180
Tradename:Theolair, Slo-Bid
Pregnancy Au:A
Pregnancy Us:C
Legal Au:S4
Legal Ca:Rx-only
Legal Uk:P
Legal Us:Rx-only
Routes Of Administration:oral, IV, rectal
Bioavailability:100% (oral)
Protein Bound:40% (primarily to albumin)
Metabolism:Hepatic

CYP1A2, CYP2E1, CYP3A4

Metabolites:• 1,3-Dimethyluric acid
• 1-Methyixanthine
• 3-Methylxanthine
Elimination Half-Life:5–8 hours
Cas Number:58-55-9
Atc Prefix:R03
Atc Suffix:DA04
Atc Supplemental:R03DB04
Chebi:28177
Pubchem:2153
Iuphar Ligand:413
Drugbank:DB00277
Chemspiderid:2068
Unii:0I55128JYK
Kegg:D00371
Chembl:190
C:7
H:8
N:4
O:2
Smiles:Cn1c2c(c(=O)n(c1=O)C)[nH]cn2
Stdinchi:1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)
Stdinchikey:ZFXYFBGIUFBOJW-UHFFFAOYSA-N

Theophylline, also known as 1,3-dimethylxanthine, is a drug that inhibits phosphodiesterase and blocks adenosine receptors.[1] It is used to treat chronic obstructive pulmonary disease (COPD) and asthma.[2] Its pharmacology is similar to other methylxanthine drugs (e.g., theobromine and caffeine).[1] Trace amounts of theophylline are naturally present in tea, coffee, chocolate, yerba maté, guarana, and kola nut.[1] [3]

The name 'theophylline' derives from "Thea"—the former genus name for tea + Legacy Greek φύλλον (phúllon, "leaf") + -ine.

Medical uses

The main actions of theophylline involve:[2]

The main therapeutic uses of theophylline are for treating:[2]

Performance enhancement in sports

Theophylline and other methylxanthines are often used for their performance-enhancing effects in sports, as these drugs increase alertness, bronchodilation, and increase the rate and force of heart contraction.[9] There is conflicting information about the value of theophylline and other methylxanthines as prophylaxis against exercise-induced asthma.[10]

Adverse effects

The use of theophylline is complicated by its interaction with various drugs and by the fact that it has a narrow therapeutic window (<20 mcg/mL).[2] Its use must be monitored by direct measurement of serum theophylline levels to avoid toxicity. It can also cause nausea, diarrhea, increase in heart rate, abnormal heart rhythms, and CNS excitation (headaches, insomnia, irritability, dizziness and lightheadedness).[2] [11] Seizures can also occur in severe cases of toxicity, and are considered to be a neurological emergency.[2]

Its toxicity is increased by erythromycin, cimetidine, and fluoroquinolones, such as ciprofloxacin. Some lipid-based formulations of theophylline can result in toxic theophylline levels when taken with fatty meals, an effect called dose dumping, but this does not occur with most formulations of theophylline.[12] Theophylline toxicity can be treated with beta blockers. In addition to seizures, tachyarrhythmias are a major concern.[13] Theophylline should not be used in combination with the SSRI fluvoxamine.[14] [15]

Spectroscopy

UV-visible spectroscopy

Theophylline is soluble in 0.1N NaOH and absorbs maximally at 277 nm with an extinction coefficient of 10,200 (cm−1 M−1).[16]

Proton nuclear magnetic resonance spectroscopy (1H-NMR)

The characteristic signals, distinguishing theophylline from related methylxanthines, are approximately 3.23δ and 3.41δ, corresponding to the unique methylation possessed by theophylline. The remaining proton signal, at 8.01δ, corresponds to the proton on the imidazole ring, not transferred between the nitrogen. The transferred proton between the nitrogen is a variable proton and only exhibits a signal under certain conditions.[17]

Carbon nuclear magnetic resonance spectroscopy (13C-NMR)

The unique methylation of theophylline corresponds to the following signals: 27.7δ and 29.9δ. The remaining signals correspond to carbons characteristic of the xanthine backbone.[18]

Natural occurrences

Theophylline is naturally found in cocoa beans. Amounts as high as 3.7 mg/g have been reported in Criollo cocoa beans.[19]

Trace amounts of theophylline are also found in brewed tea, although brewed tea provides only about 1 mg/L,[20] which is significantly less than a therapeutic dose.

Trace amounts of theophylline are also found in guarana (Paullinia cupana) and in kola nuts.[21]

Pharmacology

Pharmacodynamics

Like other methylated xanthine derivatives, theophylline is both a

  1. competitive nonselective phosphodiesterase inhibitor which increases intracellular levels of cAMP and cGMP,[2] [22] activates PKA, inhibits TNF-alpha[23] [24] and inhibits leukotriene[25] synthesis, and reduces inflammation and innate immunity[25]
  2. nonselective adenosine receptor antagonist, antagonizing A1, A2, and A3 receptors almost equally, which explains many of its cardiac effects.[2] [26] Theophylline activates histone deacetylases.[2]

Pharmacokinetics

Absorption

When theophylline is administered intravenously, bioavailability is 100%.[27]

Distribution

Theophylline is distributed in the extracellular fluid, in the placenta, in the mother's milk and in the central nervous system. The volume of distribution is 0.5 L/kg. The protein binding is 40%.

Metabolism

Theophylline is metabolized extensively in the liver.[2] It undergoes N-demethylation via cytochrome P450 1A2. It is metabolized by parallel first order and Michaelis-Menten pathways. Metabolism may become saturated (non-linear), even within the therapeutic range. Small dose increases may result in disproportionately large increases in serum concentration. Methylation to caffeine is also important in the infant population. Smokers and people with hepatic (liver) impairment metabolize it differently.[2] Cigarette and marijuana smoking induces metabolism of theophylline, increasing the drug's metabolic clearance.[28] [29]

Excretion

Theophylline is excreted unchanged in the urine (up to 10%). Clearance of the drug is increased in children (age 1 to 12), teenagers (12 to 16), adult smokers, elderly smokers, as well as in cystic fibrosis, and hyperthyroidism. Clearance of the drug is decreased in these conditions: elderly, acute congestive heart failure, cirrhosis, hypothyroidism and febrile viral illnesses.[2]

The elimination half-life varies: 30 hours for premature neonates, 24 hours for neonates, 3.5 hours for children ages 1 to 9, 8 hours for adult non-smokers, 5 hours for adult smokers, 24 hours for those with hepatic impairment, 12 hours for those with congestive heart failure NYHA class I-II, 24 hours for those with congestive heart failure NYHA class III-IV, 12 hours for the elderly.

History

Theophylline was first extracted from tea leaves and chemically identified around 1888 by the German biologist Albrecht Kossel.[30] [31] Seven years later, a chemical synthesis starting with 1,3-dimethyluric acid was described by Emil Fischer and Lorenz Ach.[32] The Traube purine synthesis, an alternative method to synthesize theophylline, was introduced in 1900 by another German scientist, Wilhelm Traube.[33] Theophylline's first clinical use came in 1902 as a diuretic.[34] It took an additional 20 years until it was first reported as an asthma treatment.[35] The drug was prescribed in a syrup up to the 1970s as Theostat 20 and Theostat 80, and by the early 1980s in a tablet form called Quibron.

Notes and References

  1. Web site: Theophylline . PubChem, US National Library of Medicine . 2 September 2023 . 26 August 2023.
  2. Barnes PJ . Theophylline . American Journal of Respiratory and Critical Care Medicine . 188 . 8 . 901–906 . October 2013 . 23672674 . 10.1164/rccm.201302-0388PP.
  3. ((IARC Working Group on the Evaluation of Carcinogenic Risks to Humans)) . Coffee, Tea, Mate, Methylxanthines and Methylglyoxal. . IARC Monographs on the Evaluation of Carcinogenic Risks to Humans . 51 . 391–419 . 1991 . 2033791 . 7681294 . International Agency for Research on Cancer .
  4. Eldridge FL, Millhorn DE, Kiley JP . Antagonism by theophylline of respiratory inhibition induced by adenosine . Journal of Applied Physiology . 59 . 5 . 1428–1433 . November 1985 . 4066573 . 10.1152/jappl.1985.59.5.1428 .
  5. Mahemuti G, Zhang H, Li J, Tieliwaerdi N, Ren L . Efficacy and side effects of intravenous theophylline in acute asthma: a systematic review and meta-analysis . Drug Design, Development and Therapy . 12 . 99–120 . 10 January 2018 . 29391776 . 5768195 . 10.2147/DDDT.S156509 . free .
  6. Miao Y, Zhou Y, Zhao S, Liu W, Wang A, Zhang Y, Li Y, Jiang H . 3 . Comparative efficacy and safety of caffeine citrate and aminophylline in treating apnea of prematurity: A systematic review and meta-analysis . PLOS ONE . 17 . 9 . e0274882 . 19 September 2022 . 36121807 . 9484669 . 10.1371/journal.pone.0274882 . free . 2022PLoSO..1774882M .
  7. Hung KC, Ho CN, Chen IW, Hung IY, Lin MC, Lin CM, Wang LK, Chen JY, Sun CK . 6 . The impact of aminophylline on incidence and severity of post-dural puncture headache: A meta-analysis of randomised controlled trials . Anaesthesia, Critical Care & Pain Medicine . 40 . 4 . 100920 . August 2021 . 34186265 . 10.1016/j.accpm.2021.100920 . 235686558 .
  8. Barati-Boldaji R, Shojaei-Zarghani S, Mehrabi M, Amini A, Safarpour AR . Post-dural puncture headache prevention and treatment with aminophylline or theophylline: a systematic review and meta-analysis . Anesthesia and Pain Medicine . 18 . 2 . 177–189 . April 2023 . 37183286 . 10.17085/apm.22247 . 10183611 .
  9. Watson CJ, Stone GL, Overbeek DL, Chiba T, Burns MM . Performance-enhancing drugs and the Olympics . Journal of Internal Medicine . 291 . 2 . 181–196 . February 2022 . 35007384 . 10.1111/joim.13431 . 245855348 .
  10. Pigakis KM, Stavrou VT, Pantazopoulos I, Daniil Z, Kontopodi AK, Gourgoulianis K . Exercise-Induced Bronchospasm in Elite Athletes . Cureus . 14 . 1 . e20898 . January 2022 . 35145802 . 10.7759/cureus.20898 . free . 8807463 .
  11. Web site: Theophylline . https://web.archive.org/web/20160705111407/https://www.nlm.nih.gov/medlineplus/druginfo/meds/a681006.html . MedlinePlus Drug Information. July 5, 2016. U.S. National Library of Medicine .
  12. Hendeles L, Weinberger M, Milavetz G, Hill M, Vaughan L . Food-induced "dose-dumping" from a once-a-day theophylline product as a cause of theophylline toxicity . Chest . 87 . 6 . 758–765 . June 1985 . 3996063 . 10.1378/chest.87.6.758 . 1133968 .
  13. Seneff M, Scott J, Friedman B, Smith M . Acute theophylline toxicity and the use of esmolol to reverse cardiovascular instability . Annals of Emergency Medicine . 19 . 6 . 671–673 . June 1990 . 1971502 . 10.1016/s0196-0644(05)82474-6 .
  14. DeVane CL, Markowitz JS, Hardesty SJ, Mundy S, Gill HS . Fluvoxamine-induced theophylline toxicity . The American Journal of Psychiatry . 154 . 9 . 1317–1318 . September 1997 . 9286199 . 10.1176/ajp.154.9.1317b .
  15. Sperber AD . Toxic interaction between fluvoxamine and sustained release theophylline in an 11-year-old boy . Drug Safety . 6 . 6 . 460–462 . November 1991 . 1793525 . 10.2165/00002018-199106060-00006 . 21875026 .
  16. Schack JA, Waxler SH . An ultraviolet spectrophotometric method for the determination of theophylline and theobromine in blood and tissues . The Journal of Pharmacology and Experimental Therapeutics . 97 . 3 . 283–291 . November 1949 . 15392550 .
  17. Shelke RU, Degani MS, Raju A, Ray MK, Rajan MG . Fragment Discovery for the Design of Nitrogen Heterocycles as Mycobacterium tuberculosis Dihydrofolate Reductase Inhibitors . Archiv der Pharmazie . 349 . 8 . 602–613 . August 2016 . 27320965 . 10.1002/ardp.201600066 . 40014874 .
  18. Pfleiderer W . Pteridines. Part CXIX. A New Pteridine–Purine Transformation. . Helvetica Chimica Acta . February 2008 . 91 . 2 . 338–353 . 10.1002/hlca.200890039 .
  19. Book: Caffeine . Methylxanthine composition and consumption patterns of cocoa and chocolate products and their uses . Apgar JL, Tarka Jr SM . Spiller GA . CRC Press . 1998 . 978-0-8493-2647-9 . 171 . https://books.google.com/books?id=WxmBmvhsoZ8C&pg=PA171 . 2013-11-10 .
  20. Web site: TABLE 2a: Concentrations of caffeine, theobromine and theophylline in tea products. . Food Surveillance Information Sheet Number 103 . MAFF, Department of Health and the Scottish Executive . https://web.archive.org/web/20060927200412/http://archive.food.gov.uk/maff/archive/food/infsheet/1997/no103/table2a.htm . 2006-09-27 .
  21. Belliardo F, Martelli A, Valle MG . HPLC determination of caffeine and theophylline in Paullinia cupana Kunth (guarana) and Cola spp. samples . Zeitschrift für Lebensmittel-Untersuchung und -Forschung . 180 . 5 . 398–401 . May 1985 . 4013524 . 10.1007/BF01027774 . 40205323 .
  22. Essayan DM . Cyclic nucleotide phosphodiesterases . The Journal of Allergy and Clinical Immunology . 108 . 5 . 671–680 . November 2001 . 11692087 . 10.1067/mai.2001.119555 . free .
  23. Deree J, Martins JO, Melbostad H, Loomis WH, Coimbra R . Insights into the regulation of TNF-alpha production in human mononuclear cells: the effects of non-specific phosphodiesterase inhibition . Clinics . 63 . 3 . 321–328 . June 2008 . 18568240 . 2664230 . 10.1590/S1807-59322008000300006 .
  24. Marques LJ, Zheng L, Poulakis N, Guzman J, Costabel U . Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages . American Journal of Respiratory and Critical Care Medicine . 159 . 2 . 508–511 . February 1999 . 9927365 . 10.1164/ajrccm.159.2.9804085 .
  25. Peters-Golden M, Canetti C, Mancuso P, Coffey MJ . Leukotrienes: underappreciated mediators of innate immune responses . Journal of Immunology . 174 . 2 . 589–594 . January 2005 . 15634873 . 10.4049/jimmunol.174.2.589 . free .
  26. Daly JW, Jacobson KA, Ukena D . Adenosine receptors: development of selective agonists and antagonists . Progress in Clinical and Biological Research . 230 . 1 . 41–63 . 1987 . 3588607 .
  27. Book: Griffin JP . The Textbook of Pharmaceutical Medicine . 2009 . Wiley-Blackwell . Chichester . 978-1-4051-8035-1 . 6th.
  28. Jenne JW, Nagasawa HT, Thompson RD . Relationship of urinary metabolites of theophylline to serum theophylline levels . Clinical Pharmacology and Therapeutics . 19 . 3 . 375–381 . March 1976 . 1261172 . 10.1002/cpt1976193375 . 33943915 .
  29. Jusko WJ, Schentag JJ, Clark JH, Gardner M, Yurchak AM . Enhanced biotransformation of theophylline in marihuana and tobacco smokers . Clinical Pharmacology and Therapeutics . 24 . 4 . 405–410 . October 1978 . 688731 . 10.1002/cpt1978244406 . 44613672 .
  30. Kossel A . Über eine neue Base aus dem Pflanzenreich . About a new base from the plant kingdom . de . Berichte der Deutschen Chemischen Gesellschaft . Reports of the German Chemical Society . 21 . 2164–2167 . 1888 . 10.1002/cber.188802101422 .
  31. Kossel A . Über das Theophyllin, einen neuen Bestandtheil des Thees . On theophylline, a new component of tea . de . Hoppe-Seyler's Zeitschrift für Physiologische Chemie . Hoppe-Seyler's Journal of Physiological Chemistry . 13 . 298–308 . 1889 .
  32. Fischer E, Ach L . Synthese des Caffeins . Synthesis of caffeine . de . Berichte der Deutschen Chemischen Gesellschaft . Reports of the German Chemical Society . 28 . 3. 3139 . 1895 . 10.1002/cber.189502803156.
  33. Traube W . Der synthetische Aufbau der Harnsäure, des Xanthins, Theobromins, Theophyllins und Caffeïns aus der Cyanessigsäure . The synthetic structure of uric acid, xanthine, theobromine, theophylline and caffeine from cyanoacetic acid . de. Berichte der Deutschen Chemischen Gesellschaft . Reports of the German Chemical Society . 33 . 3 . 3035–3056 . 1900 . 10.1002/cber.19000330352 .
  34. Minkowski O . Über Theocin (Theophyllin) als Diureticum . About theocine (theophylline) as a diuretic . de . Therapie der Gegenwart . Therapy of the Present . 43 . 490–493 . 1902 .
  35. Schultze-Werninghaus G, Meier-Sydow J . The clinical and pharmacological history of theophylline: first report on the bronchospasmolytic action in man by S. R. Hirsch in Frankfurt (Main) 1922 . Clinical Allergy . 12 . 2 . 211–215 . March 1982 . 7042115 . 10.1111/j.1365-2222.1982.tb01641.x . 38178598 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Theophylline".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.